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Abstract
Background The laparoscopic approach in distal pancreatectomy is associated with higher rates of splenic preservation com-
pared to open surgery. Although favorable postoperative short-term outcomes have been reported in open spleen-preserving 
distal pancreatectomy when compared to distal pancreatectomy with splenectomy, it is unclear whether this observation 
applies to the laparoscopic approach. The aim of this study is to compare laparoscopic spleen-preserving distal pancreatec-
tomy (LSPDP) with laparoscopic distal pancreatectomy with splenectomy (LDPS).
Study design This is a UK wide, propensity score-matched study, including patients who underwent LSPDP or LDPS 
between 2006 and 2016. Short-term outcomes were compared between LSPDP and LDPS according to intention to treat. 
Additionally, risk factors for unplanned splenectomy were explored.
Results A total of 456 patients were included from eleven centers (229 LSPDP and 227 LDPS). We were able to match 
173 LSPDP cases to 173 LDPS cases, according to intention to treat. No differences were seen in postoperative morbidity 
between the groups. The only identified risk factor for unplanned splenectomy was tumor size ≥ 30 mm.
Conclusions Preserving the spleen during laparoscopic distal pancreatectomy is not associated with a lower postoperative 
morbidity compared to sacrificing the spleen. Tumor size is a risk factor for unplanned splenectomy.
Keywords Laparoscopic distal pancreatectomy · Laparoscopic spleen-preserving distal pancreatectomy · Splenectomy · 
Benign · Low-grade malignant
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Abbreviations
LSPDP  Laparoscopic spleen-preserving distal 
pancreatectomy
LDPS  Laparoscopic distal pancreatectomy with 
splenectomy
SVP  Splenic vessel preservation
WT  Warshaw technique
OT  Operative time
EBL  Estimated blood loss
ISGPS  International Study Group on Pancreatic Surgery
POPF  Postoperative pancreatic fistula
SD  Standard deviation
IQR  Interquartile ranges
LOS  Length of stay
Splenic preservation has been advocated in patients under-
going distal pancreatectomy for benign or low-grade malig-
nant lesions because of its hematological and immunological 
advantages [1–4]. The two most commonly used spleen-pre-
serving techniques are the splenic vessel preservation (SVP), 
where the splenic artery and vein are preserved [2]; and the 
Warshaw technique (WT), where the splenic artery and vein 
are ligated and perfusion of the spleen is maintained by the 
short gastric and the left gastroepiploic vessels [1].
Historically, distal pancreatectomy has been carried out 
with concomitant splenectomy as a result of the spleen hav-
ing anatomical proximity to, and sharing principal vessels 
with, the left pancreas [5]. However, splenectomy comes 
with certain consequences; patients are at increased risk 
of developing severe septic complications such as over-
whelming post-splenectomy infection (OPSI) syndrome 
[6], thromboembolic events [7] as well as developing cer-
tain malignancies [8, 9]. Moreover, two meta-analyses have 
shown favorable short-term outcomes in spleen-preserving 
distal pancreatectomy compared with distal pancreatectomy 
with splenectomy [10, 11]. However, the vast majority of 
patients included in these meta-analyses underwent open 
surgery. Nowadays, laparoscopic distal pancreatectomy has 
become the preferred approach, especially for benign and 
low-grade malignant lesions [12] [13]. There are a limited 
number of studies comparing laparoscopic spleen-preserv-
ing distal pancreatectomy (LSPDP) with laparoscopic distal 
pancreatectomy with splenectomy (LDPS) and the reported 
results on postoperative morbidity are inconsistent [14–18]. 
Moreover, outcomes are likely to be impacted by treatment 
allocation bias due to the retrospective nature of the studies 
and the conversion from LSPDP to LDPS due to intraopera-
tive events.
The aims of this study are to compare short-term out-
comes after LSPDP and LDPS in patients with benign and 
low-grade malignant lesions of the distal pancreas, using 
intention-to-treat analysis and propensity score matching, 
as well as to explore risk factors of unplanned splenectomy 
in intended LSPDP.
Methods
Study design
This retrospective cohort study was performed among 
eleven tertiary referral centers throughout the UK. Data 
were collected from consecutive patients who underwent 
LSPDP or LDPS between February 2006 and December 
2016. The eligibility for splenic preservation was judged 
by a multi-disciplinary team (MDT) based on radiologi-
cal and histological characteristics of the lesion and sur-
geons’ experience. Indications for splenectomy included 
suspected pancreatic ductal adenocarcinoma (PDAC), sus-
pected lymphoma, presence of concomitant splenic vein 
thrombosis, suspected MCN larger than 4 cm, lesions in 
close proximity to the splenic hilum and NET with a high 
Ki67 index. All patients with definitive diagnosis of PDAC 
and lymphoma were excluded from analysis. Patients were 
analyzed according to intention to treat.
Our study was based on an anonymized database, 
therefore, ethical review was not required according to 
Health Research Authority (HRA) regulations. Accord-
ing to the HRA, both Research Ethics Committee (REC) 
and HRA approval are not required for research databases, 
this includes the release of non-identifiable data for analy-
sis. Due to the retrospective nature of the study, written 
informed consent was not obtained.
Outcome measures
Demographics and tumor characteristics included age, sex, 
tumor size, and histopathologic diagnosis. Perioperative 
outcome measures were operative time (OT), estimated 
blood loss (EBL), conversion to laparotomy, extended dis-
tal pancreatectomy [as defined by the International Study 
Group on Pancreatic Surgery (ISGPS)] [19], postoperative 
blood transfusion and number of units, length of hospital 
stay (LOS), reoperation, 30-day morbidity, and 30-day 
mortality. Complications were classified according to the 
Clavien–Dindo classification, major complications were 
defined as 3a or above [20]. Postoperative pancreatic fis-
tulas (POPF) were defined and classified according to the 
definition of the ISGPS [21]. POPF grade A was consid-
ered an asymptomatic biochemical leak and not counted 
as a complication, according to the modifications of the 
ISGPS definition of POPF [22].
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Surgical procedure
Similar surgical techniques were used in all centers with 
minor variation in regard to patient’s and surgeon’s posi-
tion. The detailed procedure has been previously described 
by some of our authors [23–26]. A similar technique was 
adopted in all centers. In brief, five ports (three 5-mm 
ports and two 10/12-mm ports) were used. After accessing 
the lesser sac, intraoperative ultrasound was performed if 
deemed necessary by the performing surgeon and pancreatic 
dissection was started using an ultrasonic or bipolar dissec-
tor by mobilizing the lower pancreatic margin and gaining 
access to the posterior pancreatic surface. A tape was placed 
around the pancreas and lifted to expose surgical planes. 
The pancreas was divided by using an endoscopic stapler 
(Echelon 60, Ethicon EndoSurgery, Cincinnati, OH or Tri-
Staple™, Medtronic). In cases of LDPS, the spleen was 
mobilized to be retrieved en-block with the pancreas. The 
specimen was removed through a Pfannenstiel incision using 
an impermeable bag (Endocatch, Ethicon EndoSurgery). 
The two most commonly used spleen-preserving techniques 
were SVP, as described by Kimura and colleagues [2] and 
the WT [1]. In general, SVP was performed in those without 
evidence of vascular involvement. Any need to perform War-
shaw technique procedure was due to the unexpected need 
to divide a vessel. The viability of the spleen was assessed 
based on the visual aspect of the spleen.
All patients who were planned to undergo a splenec-
tomy were vaccinated preoperatively, if time permitted. 
If not, vaccination took place on 2 weeks postoperatively. 
Patients who were planned for LSPDP were not vaccinated 
preoperatively.
Propensity score matching
To minimize the impact of treatment allocation bias, patients 
who were planned to undergo LSPDP were matched to 
patients who were planned for LDPS, using propensity 
scores. Propensity scores were based on the following base-
line variables: age, sex, and tumor size. Matching was per-
formed on a nearest neighbor basis, in a 1:1 ratio without 
replacement and with a caliper width of 0.01. Balance was 
assessed using the standardized mean difference (SMD). 
Optimal balance is achieved when SMD is 0.1 or below.
Statistical analysis
Normally distributed continuous variables are expressed 
as means with standard deviation (SD). Non-normally dis-
tributed variables are reported as medians with interquar-
tile ranges (IQR) or full ranges. Outcomes were compared 
using the independent samples t test for normally distrib-
uted variables. The Mann–Whitney U test was used to 
compare non-normally distributed variables. Categorical 
variables were compared by Chi-square or Fisher’s exact 
test as appropriate. Logistic regression was carried out to 
identify risk factors for unplanned splenectomy; variables 
with a p-value < 0.2 in univariable analysis were subse-
quently entered in a multivariable logistic regression. A 
two-tailed p-value < 0.05 was considered statistically sig-
nificant. Data were analyzed using  SPSS® 24.0 software 
(SPSS, Chicago, IL, USA).
Results
Patient characteristics
In total, 571 patients underwent laparoscopic distal pan-
createctomy during the study period. Overall, 115 patients 
were excluded; 85 patients with PDAC, two with lym-
phoma, and 28 because the intended approach (spleen pre-
serving or splenectomy) was not reported. The remaining 
456 patients were included for analysis. The mean age 
of the cohort was 56 ± 16 years old and 293 (64%) were 
female. The most common histopathologic diagnoses were 
neuroendocrine tumor (NET), mucinous cystic neoplasm 
(MCN), and intraductal papillary mucinous neoplasm 
(IPMN). LSPDP was attempted in 229 patients, in whom 
splenic preservation was achieved in 184 (80%), some 45 
(20%) were converted to LDPS. Of the 184 LSPDP, 124 
were performed according to SVP [2] and 60 according to 
the Warshaw technique [1]. A total of 227 patients were 
planned to undergo LDPS, an additional 45 patients under-
went unplanned splenectomy, therefore the total number of 
patients in whom LDPS was performed was 272. We were 
able to match 173 cases of intended LSPDP to 173 cases 
of intended LDPS. Of those 173 LSPDP, 150 patients 
underwent splenic preservation; SVP in 101 patients and 
the Warshaw technique in 49 patients. Figure 1 shows the 
study flowchart of the study.
Baseline characteristics of LSPDP and LDPS before 
propensity score matching are shown in Table 1. There 
was unbalance between the two groups in terms of age 
(55 ± 16  years in LSPDP and 57 ± 16  years in LDPS, 
SMD = 0.13), sex (67% female in LSPDP and 61% female 
in LDPS, SMD = 0.14), and tumor size (30 ± 21 mm versus 
37 ± 25 mm in LSPDP and LDPS, SMD = 0.30). Table 2 
presents the baseline characteristics after propensity score 
matching, which shows there is optimal balance in terms of 
sex (63% and 65% female in LSPDP and LDPS, respectively, 
SMD = 0.05) and tumor size (32 ± 21 mm in LSPDP and 
33 ± 22 mm in LDPS, SMD = 0.05. For age, optimal balance 
was not reached (58 ± 15 years in LSPDP and 56 ± 16 years 
in LDPS, SMD = 0.13).
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Perioperative outcomes
Table 3 shows the perioperative outcomes of LSPDP ver-
sus LDPS before propensity score matching. In the LSPDP 
group, the mean operative time (OT) was 26 min shorter 
than in LDPS, p = 0.002. The estimated blood loss (EBL) 
during LSPDP was 150 ml (100–300), which was compara-
ble to LDPS: 200 ml (100–320), p = 0.12. A postoperative 
blood transfusion was given in 14/229 (6%) in the LSPDP 
group and in 21/227 (10%) in the LDPS group, p = 0.13. 
Conversion to laparotomy was required in 21/229 (9%) 
patients undergoing LSPDP and in 34/227 (15%) in the 
LDPS group, p = 0.06. Postoperative complication rate and 
the incidence of POPF grade B or C were comparable in 
both groups. The median length of hospital stay (LOS) was 
one day shorter after LSPDP than after LDPS (6 days (5–8) 
vs. 7 days (5 – 9), p = 0.01). A total of 16 patients developed 
some degree of splenic ischemia, of which four had under-
gone SVP and 12 the Warshaw technique. All 16 patients 
were managed conservatively.
Table 4 shows the demographics and tumor characteristics 
of LSPDP and LDPS after propensity score matching. The 
number of patients after matching was 173 in both groups. 
The OT was 20 min shorter in LSPDP (234 ± 77 min) com-
pared to LDPS (256 ± 88 min), p = 0.02. EBL during LSPDP 
was comparable with the blood loss during LDPS. However, 
the proportion of patients needing a postoperative blood 
transfusion was less after LSPDP (4%) compared to LDPS 
(11%), p = 0.02. Conversion to laparotomy was required in 
a comparable number of patients undergoing LSPDP and 
LDPS. The postoperative complication rate and the inci-
dence of POPF grade B or C were similar in both groups, as 
Fig. 1  Study flowchart. LDP Laparoscopic distal pancreatectomy, LSPDP Laparoscopic spleen-preserving distal pancreatectomy, PDAC Pancre-
atic ductal adenocarcinoma
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was the LOS. A total of 13 patients developed some degree 
of splenic ischemia, of which four had undergone SVP and 
nine the Warshaw technique. All 13 patients were managed 
conservatively.
Unplanned splenectomy
Table 5 shows the univariable logistic regression of risk 
factors for unplanned splenectomy during intended LSPDP. 
Table 1  Patient and tumor 
characteristics before matching
LSPDP laparoscopic spleen-preserving distal pancreatectomy, LDPS laparoscopic distal pancreatectomy 
with splenectomy, SMD standardized mean difference, NET neuroendocrine tumor, MCN mucinous cystic 
neoplasm, SCN serous cystic neoplasm, IPMN intraductal papillary mucinous neoplasm, RCC renal cell 
carcinoma, SPT solid papillary tumor
LSPDP (N = 229) LDPS (N = 227) P-value SMD
Age, years (SD) 55 (16) 57 (16) 0.21 0.13
Female, n (%) 154 (67) 139 (61) 0.18 0.14
Tumor size, mm (IQR) 30 (21) 37 (25) 0.002 0.30
Histology, n (%)
 NET 87 (38) 70 (31)
 MCN 50 (22) 63 (28)
 SCN 27 (12) 13 (6)
 IPMN 21 (9) 39 (17)
 Chronic pancreatitis/pseudocyst 13 (5.5) 22 (10)
 Other cyst 7 (3) 6 (2.5)
 RCC metastasis 7 (3) 3 (1)
 SPT 6 (2.5) 6 (2.5)
 No tumor 4 (1.5) –
 Other metastasis 2 (1) 3 (1)
 GIST 2 (1) 2 (1)
 Other 2 (1) –
 Acinar cell carcinoma 1 (0.5) –
Table 2  Patient and tumor 
characteristics after matching
LSPDP laparoscopic spleen-preserving distal pancreatectomy, LDPS laparoscopic distal pancreatectomy 
with splenectomy, SMD standardized mean difference, NET neuroendocrine tumor, MCN mucinous cystic 
neoplasm, SCN serous cystic neoplasm, IPMN intraductal papillary mucinous neoplasm, RCC renal cell car-
cinoma, SPT solid papillary tumor
LSPDP (N = 173) LDPS (N = 173) P-value SMD
Age, years (SD) 58 (15) 56 (16) 0.26 0.13
Female, n (%) 109 (63) 112 (65) 0.74 0.05
Tumor size, mm (SD) 32 (21) 33 (22) 0.55 0.05
Histology, n (%)
 NET 66 (38) 57 (33)
 MCN 43 (25) 51 (29)
 SCN 20 (11.5) 8 (5)
 IPMN 20 (11.5) 29 (17)
 Chronic pancreatitis/pseudocyst 8 (5) 14 (8)
 Other cyst 7 (4) 5 (3)
 RCC metastasis 3 (2) 1 (0.5)
 SPT – 5 (3)
 No tumor 1 (0.5) –
 Other metastasis 2 (1) 3 (1.5)
 Other 1 (0.5) –
 GIST 1 (0.5) –
 Acinar cell carcinoma 1 (0.5) –
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Table 3  Perioperative outcomes 
before matching
LSPDP laparoscopic spleen-preserving distal pancreatectomy, LDPS laparoscopic distal pancreatectomy 
with splenectomy, SVP splenic vessel preservation, POPF postoperative pancreatic fistula
Intraoperative outcomes LSPDP (N = 229) LDPS (N = 227) P-value
Splenic preservation, n (%) 184 (80) – –
 SVP, n (%) 124 (67) – –
 Warshaw technique, n (%) 60 (33) – –
Operative time, min (SD) 231 (79) 257 (87) 0.002
Estimated blood loss, mL (IQR) 150 (100–300) 200 (100–320) 0.18
Conversion, n (%) 21 (9) 34 (15) 0.06
Extended distal pancreatectomy, n (%) 9 (4) 8 (4) 0.82
Postoperative outcomes
Complications, n (%) 89 (41) 100 (45) 0.49
Major complications, n (%) 32 (14) 35 (16) 0.68
POPF B/C, n (%) 36 (16) 41 (18) 0.49
Grade 0.41
 B 30 31 –
 C 6 10 –
Splenic ischemia, n (%) 16 (7) – –
30-day mortality, n (%) 2 (1) – 0.50
Reoperation, n (%) 12 (5) 9 (4) 0.50
Hospital stay, days (IQR) 6 (5–8) 7 (5–9) 0.01
Blood transfusion, n (%) 14 (6) 21 (10) 0.13
Units, n (range) 2 (1–6) 2 (1–14) 0.63
Table 4  Perioperative outcomes 
after matching
LSPDP laparoscopic spleen-preserving distal pancreatectomy, LDPS laparoscopic distal pancreatectomy 
with splenectomy, SVP splenic vessel preservation, POPF postoperative pancreatic fistula
Intraoperative outcomes LSPDP (N = 173) LDPS (N = 173) P-value
Splenic preservation, n (%) 150 (87) – –
 SVP, n (%) 101 (67) – –
 Warshaw technique, n (%) 49 (33) – –
Operative time, min (SD) 234 (77) 256 (88) 0.02
Estimated blood loss, mL (IQR) 150 (100–270) 175 (100–315) 0.24
Conversion, n (%) 16 (9) 22 (13) 0.30
Extended distal pancreatectomy, n (%) 7 (4) 6 (4) 0.78
Postoperative outcomes
 Complications, n (%) 73 (42) 77 (45) 0.95
 Major complications, n (%) 28 (17) 25 (15) 0.60
 POPF B/C, n (%) 31 (18) 27 (16) 0.58
 Grade 0.36
  B 26 20 –
  C 5 7 –
 Splenic ischemia, n (%) 13 (8) – –
 30-day mortality, n (%) 1 (0.5) – 0.50
 Reoperation, n (%) 10 (6) 6 (4) 0.29
 Hospital stay, days (IQR) 6 (5–8) 7 (5–8) 0.22
 Blood transfusion, n (%) 7 (4) 17 (11) 0.02
 Units, n (range) 2 (1–2) 2 (1–14) 0.50
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Multivariable analysis was not performed as only one vari-
able reached a p-value < 0.2. Therefore, the sole identified 
risk factor for unplanned splenectomy in intended LSPDP 
in this study was tumor size ≥ 30 mm (OR = 2.279 [1.16 
– 4.48], p = 0.02).
Discussion
In this study, splenic preservation was achieved in 80% of 
intended LSPDP, while splenic preservation rates in lapa-
roscopic cohorts in the literature vary between 29 and 86% 
[14, 16, 18]. This variation could be explained by differences 
in surgeon’s experience in performing laparoscopic distal 
pancreatectomy, the long learning curve [27] as well as the 
preferred technique of splenic preservation (SVP or WT).
Differences in short-term outcomes between LSPDP and 
LDPS, in our intention-to-treat analysis, before matching, 
included a shorter OT and a shorter LOS in the LSPDP 
group. However, after propensity score matching only OT 
was confirmed to be shorter in LSPDP.
Similarly, Dai and colleagues, who performed a retro-
spective cohort study comparing LSPDP and LDPS using 
intention-to-treat analysis, reported a shorter OT and less 
EBL in the LSPDP group [14]. After propensity score 
matching, only a shorter OT in LSPDP was confirmed. This 
emphasizes the importance of propensity score matching 
in minimizing the allocation treatment bias and offering a 
more sound evidence on the difference between treatment 
modalities near to what can be achieved in a randomization 
setting [28].
A possible explanation for a longer OT if splenectomy 
is performed is the need for complete mobilization of the 
pancreas and its vessels, with complete dissection of the ret-
roperitoneal reflection. Whereas, in LSPDP, this mobiliza-
tion is not or only partially needed. In addition, if the spleen 
is not removed it does not need mobilization either, which 
potentially saves time. Another possible explanation for the 
shorter OT in LSPDP is that LSPDP might have been per-
formed by more experienced surgeons compared to LDPS.
No differences were seen in 30-day complication rate or 
in the incidence of POPF, both before and after matching. 
Interestingly, a meta-analysis by Shi and colleagues reported 
less overall morbidity, fewer postoperative infections, less 
EBL, and a lower rate of POPF in spleen-preserving distal 
pancreatectomy (SPDP) compared to distal pancreatectomy 
with splenectomy (DPS) [10]. Another meta-analysis by He 
and colleagues showed a lower incidence of intra-abdominal 
abscesses in SPDP and a shorter LOS but no difference in 
overall morbidity or POPF rate, compared to DPS [11???]. 
The reduction of morbidity demonstrated in the aforemen-
tioned meta-analyses is not consistent with our results or 
with the report by Dai and colleagues. One explanation 
might be that the vast majority of the patients included in 
these meta-analyses underwent open surgery. Possibly, the 
laparoscopic approach has a greater favorable impact on the 
short-term outcomes leading less complications regardless 
of the splenic preservation, as it is previously demonstrated 
that laparoscopic distal pancreatectomy is associated with 
lower morbidity [29–32], shorter hospital stay, and less 
blood loss [12, 29, 30] compared to open distal pancrea-
tectomy. Moreover, it is likely that treatment allocation bias 
played a role in these meta-analyses, as all studies included 
were retrospective cohort studies that analyzed cases of 
unplanned splenectomy in the DPS group. This group of 
unplanned splenectomies can greatly affect outcomes, as 
unplanned splenectomies are most likely to be the conse-
quence of uncontrollable bleeding from the splenic vessels. 
Therefore, in the current study, unplanned splenectomies 
were analyzed in the LSPDP group.
Interestingly, the current study showed that a smaller pro-
portion of patients received a postoperative blood transfu-
sion after LSPDP than after LDPS, even though, EBL was 
comparable in both groups (150 ml vs. 200 ml in LSPDP and 
LDPS, respectively). Possibly, patients in the LDPS group 
were more likely to have comorbidities and therefore had 
a lower threshold for receiving a blood transfusion. As no 
parameters on preoperative fitness or comorbidities were 
documented in this study, this outcome should be interpret 
with caution.
This study has some other limitations. First, the retro-
spective nature could have led to treatment allocation bias, 
as the group of patients undergoing LSPDP was selected 
based on the judgement of the MDT, where the feasibility 
of splenic preservation could have played a major role, lead-
ing to less complex cases in the LSPDP group. However, 
treatment allocation bias has been minimized by perform-
ing intention-to-treat analysis and propensity score match-
ing. Second, there might have been differences in indication 
for LSPDP and LDPS between the different centers. The 
strengths of this study are that, to the best of our knowledge, 
Table 5  Univariable analysis of risk factors for splenectomy in 
intended splenic preservation
Univariable
Odds ratio (95% CI) P-value
Age
 ≥ 60 years old 0.77 (0.39–1.51) 0.45
Sex
 Female 0.76 (0.39–1.52) 0.45
Tumor size
 ≥ 30 mm 2.28 (1.16–4.48) 0.02
Extended distal pancrea-
tectomy
2.31 (0.53–10.08) 0.26
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this is the largest cohort comparing LSPDP and LDPS, the 
second study to match these groups using propensity scores, 
and having very similar results to the other propensity score-
matched study.
Conclusions
A high splenic preservation rate was achieved with tumor 
size as a risk factor for unplanned splenectomy. Preserving 
the spleen during laparoscopic distal pancreatectomy is not 
associated with a lower postoperative morbidity compared 
to sacrificing the spleen. However, taking in considera-
tion the long-term risks of post-splenectomy patients, the 
authors believe splenic preservation should be attempted in 
laparoscopic distal pancreatectomy for benign or low-grade 
malignant lesions as this study shows the approach is safe 
and feasible.
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